Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aging | 50 | 2023 | 8651 | 2.930 |
Why?
|
Blast Injuries | 11 | 2020 | 322 | 2.740 |
Why?
|
Nerve Fibers, Myelinated | 19 | 2018 | 952 | 2.650 |
Why?
|
Cerebrovascular Circulation | 16 | 2023 | 2733 | 2.280 |
Why?
|
Alzheimer Disease | 53 | 2024 | 8547 | 2.190 |
Why?
|
Brain | 84 | 2024 | 26951 | 2.170 |
Why?
|
Veterans | 28 | 2024 | 2642 | 1.860 |
Why?
|
Cerebral Cortex | 47 | 2024 | 5761 | 1.830 |
Why?
|
Diffusion Tensor Imaging | 31 | 2024 | 2385 | 1.710 |
Why?
|
Magnetic Resonance Imaging | 124 | 2024 | 36290 | 1.610 |
Why?
|
Leukoencephalopathies | 5 | 2017 | 249 | 1.320 |
Why?
|
Brain Concussion | 10 | 2024 | 1394 | 1.260 |
Why?
|
Hippocampus | 20 | 2024 | 3738 | 1.210 |
Why?
|
Military Personnel | 5 | 2022 | 1244 | 1.050 |
Why?
|
Neural Pathways | 12 | 2019 | 3040 | 1.040 |
Why?
|
Stress Disorders, Post-Traumatic | 20 | 2024 | 4555 | 1.000 |
Why?
|
Neuropsychological Tests | 41 | 2021 | 7021 | 0.970 |
Why?
|
Spin Labels | 4 | 2023 | 336 | 0.940 |
Why?
|
Diffusion Magnetic Resonance Imaging | 18 | 2024 | 2782 | 0.900 |
Why?
|
Nerve Net | 7 | 2021 | 2261 | 0.880 |
Why?
|
Atrophy | 19 | 2022 | 1627 | 0.870 |
Why?
|
Brain Mapping | 39 | 2023 | 6568 | 0.870 |
Why?
|
Huntington Disease | 12 | 2018 | 1141 | 0.780 |
Why?
|
Longevity | 5 | 2023 | 1050 | 0.770 |
Why?
|
Executive Function | 7 | 2021 | 1374 | 0.760 |
Why?
|
Image Processing, Computer-Assisted | 35 | 2022 | 8950 | 0.740 |
Why?
|
Aged, 80 and over | 73 | 2024 | 58995 | 0.730 |
Why?
|
Afghan Campaign 2001- | 12 | 2024 | 296 | 0.720 |
Why?
|
Aged | 118 | 2024 | 169152 | 0.690 |
Why?
|
Cholesterol | 4 | 2017 | 2924 | 0.620 |
Why?
|
Cerebral Arteries | 1 | 2021 | 493 | 0.620 |
Why?
|
Corpus Callosum | 9 | 2019 | 749 | 0.600 |
Why?
|
Reaction Time | 5 | 2020 | 2075 | 0.600 |
Why?
|
Male | 165 | 2024 | 359744 | 0.600 |
Why?
|
Cognition Disorders | 15 | 2018 | 3976 | 0.580 |
Why?
|
Middle Aged | 107 | 2024 | 220352 | 0.580 |
Why?
|
Dementia | 10 | 2022 | 2649 | 0.570 |
Why?
|
Brain Injuries | 5 | 2019 | 2044 | 0.570 |
Why?
|
Prefrontal Cortex | 9 | 2021 | 2212 | 0.560 |
Why?
|
Female | 159 | 2024 | 391270 | 0.550 |
Why?
|
Humans | 222 | 2024 | 760621 | 0.540 |
Why?
|
Anisotropy | 11 | 2024 | 1278 | 0.530 |
Why?
|
Myelin Sheath | 4 | 2021 | 652 | 0.520 |
Why?
|
Parkinson Disease | 4 | 2023 | 2859 | 0.510 |
Why?
|
Nerve Degeneration | 4 | 2018 | 748 | 0.510 |
Why?
|
Adult | 105 | 2024 | 219994 | 0.510 |
Why?
|
Magnetoencephalography | 2 | 2018 | 634 | 0.500 |
Why?
|
Cognition | 16 | 2024 | 6957 | 0.490 |
Why?
|
Cerebral Amyloid Angiopathy | 7 | 2014 | 892 | 0.490 |
Why?
|
Emotional Intelligence | 1 | 2016 | 135 | 0.480 |
Why?
|
Pattern Recognition, Automated | 3 | 2020 | 994 | 0.480 |
Why?
|
Organ Size | 15 | 2021 | 2254 | 0.480 |
Why?
|
tau Proteins | 8 | 2024 | 2085 | 0.480 |
Why?
|
Gyrus Cinguli | 5 | 2021 | 1114 | 0.460 |
Why?
|
Apolipoprotein E4 | 5 | 2021 | 707 | 0.460 |
Why?
|
Limbic System | 2 | 2020 | 419 | 0.450 |
Why?
|
Entorhinal Cortex | 5 | 2024 | 286 | 0.440 |
Why?
|
Dyspnea | 1 | 2021 | 1352 | 0.430 |
Why?
|
Cerebrovascular Disorders | 5 | 2015 | 1501 | 0.410 |
Why?
|
Amnesia | 3 | 2014 | 255 | 0.410 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2016 | 284 | 0.410 |
Why?
|
Parietal Lobe | 7 | 2021 | 850 | 0.410 |
Why?
|
Locus Coeruleus | 2 | 2024 | 231 | 0.400 |
Why?
|
Levodopa | 1 | 2013 | 217 | 0.400 |
Why?
|
Antiparkinson Agents | 1 | 2013 | 183 | 0.390 |
Why?
|
Disease Progression | 17 | 2024 | 13502 | 0.380 |
Why?
|
Temporal Lobe | 7 | 2024 | 1688 | 0.380 |
Why?
|
Disease | 1 | 2016 | 671 | 0.370 |
Why?
|
Stroke | 6 | 2014 | 9962 | 0.370 |
Why?
|
Somatosensory Cortex | 1 | 2014 | 511 | 0.360 |
Why?
|
Lewy Body Disease | 2 | 2023 | 252 | 0.360 |
Why?
|
Image Interpretation, Computer-Assisted | 14 | 2020 | 3340 | 0.350 |
Why?
|
Mental Processes | 1 | 2011 | 245 | 0.350 |
Why?
|
Brain Ischemia | 4 | 2013 | 3127 | 0.340 |
Why?
|
Microvessels | 1 | 2013 | 572 | 0.330 |
Why?
|
Attention | 6 | 2021 | 2387 | 0.330 |
Why?
|
Positron-Emission Tomography | 10 | 2024 | 6465 | 0.310 |
Why?
|
Sex Characteristics | 7 | 2018 | 2629 | 0.290 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 3224 | 0.290 |
Why?
|
Motor Cortex | 1 | 2014 | 995 | 0.280 |
Why?
|
Blood Pressure | 6 | 2016 | 8525 | 0.280 |
Why?
|
Frontal Lobe | 4 | 2019 | 1420 | 0.280 |
Why?
|
Amygdala | 5 | 2021 | 1351 | 0.270 |
Why?
|
Imaging, Three-Dimensional | 9 | 2017 | 4048 | 0.270 |
Why?
|
Longitudinal Studies | 13 | 2024 | 14495 | 0.270 |
Why?
|
Diabetes Mellitus | 3 | 2022 | 5889 | 0.260 |
Why?
|
Amyloid | 5 | 2024 | 842 | 0.260 |
Why?
|
Pain | 1 | 2021 | 5066 | 0.260 |
Why?
|
Individuality | 2 | 2019 | 300 | 0.260 |
Why?
|
Diabetes, Gestational | 1 | 2015 | 1242 | 0.250 |
Why?
|
Young Adult | 29 | 2024 | 58741 | 0.250 |
Why?
|
Tissue Plasminogen Activator | 1 | 2011 | 1190 | 0.240 |
Why?
|
Insulin Resistance | 3 | 2019 | 3959 | 0.240 |
Why?
|
Hypertension | 4 | 2021 | 8594 | 0.240 |
Why?
|
Axons | 3 | 2019 | 1673 | 0.240 |
Why?
|
Parahippocampal Gyrus | 3 | 2010 | 115 | 0.240 |
Why?
|
Cluster Analysis | 4 | 2022 | 2698 | 0.230 |
Why?
|
Memory Disorders | 4 | 2015 | 1197 | 0.230 |
Why?
|
Guilt | 1 | 2024 | 96 | 0.230 |
Why?
|
Bacterial Infections | 1 | 2012 | 1403 | 0.230 |
Why?
|
September 11 Terrorist Attacks | 1 | 2024 | 105 | 0.220 |
Why?
|
Neurodegenerative Diseases | 3 | 2022 | 1084 | 0.220 |
Why?
|
Neurologic Examination | 1 | 2006 | 916 | 0.220 |
Why?
|
Cross-Sectional Studies | 15 | 2023 | 25942 | 0.210 |
Why?
|
Neuroprotective Agents | 1 | 2009 | 961 | 0.210 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2023 | 108 | 0.210 |
Why?
|
Amyloid beta-Peptides | 7 | 2024 | 3832 | 0.200 |
Why?
|
Lymphocyte Subsets | 2 | 2014 | 310 | 0.200 |
Why?
|
Psychiatric Status Rating Scales | 6 | 2017 | 6015 | 0.200 |
Why?
|
Bronchodilator Agents | 2 | 2000 | 506 | 0.190 |
Why?
|
Wireless Technology | 1 | 2022 | 98 | 0.190 |
Why?
|
Psychomotor Performance | 6 | 2020 | 1878 | 0.190 |
Why?
|
Oxygen | 4 | 2022 | 4193 | 0.190 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2023 | 269 | 0.180 |
Why?
|
Fibrinolytic Agents | 1 | 2011 | 2167 | 0.180 |
Why?
|
Aerosol Propellants | 1 | 2000 | 8 | 0.180 |
Why?
|
Parkinsonian Disorders | 1 | 2023 | 284 | 0.180 |
Why?
|
Blood Flow Velocity | 3 | 2021 | 1377 | 0.180 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2000 | 38 | 0.180 |
Why?
|
Apolipoproteins E | 6 | 2023 | 1436 | 0.180 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2016 | 727 | 0.180 |
Why?
|
Memory | 5 | 2014 | 2179 | 0.180 |
Why?
|
Serial Learning | 1 | 2020 | 41 | 0.170 |
Why?
|
Electroencephalography | 6 | 2024 | 6189 | 0.170 |
Why?
|
Cerebral Hemorrhage | 4 | 2022 | 2660 | 0.170 |
Why?
|
Rest | 3 | 2021 | 914 | 0.170 |
Why?
|
Albuterol | 1 | 2000 | 212 | 0.160 |
Why?
|
Models, Neurological | 7 | 2018 | 1758 | 0.160 |
Why?
|
Oximetry | 1 | 2022 | 461 | 0.160 |
Why?
|
Radiation Monitoring | 3 | 2008 | 103 | 0.160 |
Why?
|
Perfusion | 2 | 2020 | 1376 | 0.160 |
Why?
|
Reproducibility of Results | 13 | 2020 | 20080 | 0.160 |
Why?
|
Evoked Potentials | 1 | 2024 | 1036 | 0.150 |
Why?
|
Analysis of Variance | 6 | 2017 | 6238 | 0.150 |
Why?
|
Cough | 5 | 2003 | 595 | 0.150 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2012 | 3334 | 0.150 |
Why?
|
Diagnostic Imaging | 3 | 2008 | 3527 | 0.150 |
Why?
|
Hepatic Encephalopathy | 1 | 1999 | 144 | 0.150 |
Why?
|
Learning | 2 | 2020 | 1739 | 0.150 |
Why?
|
Internal Capsule | 3 | 2015 | 138 | 0.150 |
Why?
|
Cohort Studies | 11 | 2022 | 41335 | 0.150 |
Why?
|
Memory, Short-Term | 3 | 2019 | 978 | 0.150 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2019 | 330 | 0.150 |
Why?
|
Radiation Dosage | 5 | 2008 | 1958 | 0.140 |
Why?
|
DNA Methylation | 3 | 2016 | 4373 | 0.140 |
Why?
|
Leukoaraiosis | 1 | 2018 | 116 | 0.140 |
Why?
|
Unconsciousness | 2 | 2017 | 251 | 0.140 |
Why?
|
Age Factors | 7 | 2019 | 18416 | 0.140 |
Why?
|
Severity of Illness Index | 11 | 2018 | 15840 | 0.140 |
Why?
|
Survivors | 2 | 2024 | 2375 | 0.130 |
Why?
|
Uric Acid | 1 | 2022 | 806 | 0.130 |
Why?
|
Hyperinsulinism | 1 | 2019 | 402 | 0.130 |
Why?
|
Pilot Projects | 4 | 2022 | 8555 | 0.130 |
Why?
|
Intracranial Hemorrhages | 2 | 2012 | 844 | 0.130 |
Why?
|
Functional Laterality | 9 | 2014 | 2253 | 0.120 |
Why?
|
Asthma | 8 | 2003 | 6172 | 0.120 |
Why?
|
Statistics as Topic | 6 | 2011 | 2362 | 0.120 |
Why?
|
Catechol O-Methyltransferase | 1 | 2017 | 251 | 0.120 |
Why?
|
Genotype | 10 | 2023 | 12960 | 0.120 |
Why?
|
Exercise | 2 | 2021 | 5787 | 0.120 |
Why?
|
Diet Therapy | 1 | 2015 | 151 | 0.120 |
Why?
|
Kidney Function Tests | 1 | 2016 | 681 | 0.110 |
Why?
|
Combat Disorders | 1 | 2016 | 301 | 0.110 |
Why?
|
Radiology, Interventional | 2 | 2008 | 475 | 0.110 |
Why?
|
Infarction, Middle Cerebral Artery | 2 | 2014 | 485 | 0.110 |
Why?
|
Nervous System Diseases | 2 | 2014 | 1647 | 0.110 |
Why?
|
Radiographic Image Enhancement | 2 | 2008 | 875 | 0.110 |
Why?
|
Lipoproteins, LDL | 1 | 2016 | 641 | 0.110 |
Why?
|
Arm | 1 | 2016 | 583 | 0.110 |
Why?
|
Case-Control Studies | 11 | 2024 | 22053 | 0.110 |
Why?
|
Interview, Psychological | 1 | 2016 | 810 | 0.110 |
Why?
|
Aniline Compounds | 3 | 2024 | 1069 | 0.110 |
Why?
|
Post-Concussion Syndrome | 1 | 2015 | 238 | 0.100 |
Why?
|
Electron Transport Complex I | 1 | 2014 | 152 | 0.100 |
Why?
|
Nerve Fibers | 1 | 2016 | 708 | 0.100 |
Why?
|
Mental Recall | 2 | 2011 | 1206 | 0.100 |
Why?
|
Cerebrum | 1 | 2013 | 132 | 0.100 |
Why?
|
Heterozygote | 1 | 2019 | 2798 | 0.100 |
Why?
|
Cacao | 1 | 2013 | 98 | 0.100 |
Why?
|
Alcoholism | 2 | 2014 | 1961 | 0.100 |
Why?
|
Bacterial Translocation | 1 | 2012 | 73 | 0.100 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2013 | 165 | 0.100 |
Why?
|
Middle Cerebral Artery | 1 | 2013 | 276 | 0.100 |
Why?
|
Creatine | 1 | 2014 | 426 | 0.100 |
Why?
|
Oxidative Phosphorylation | 1 | 2014 | 495 | 0.100 |
Why?
|
Brain Diseases | 2 | 2019 | 1540 | 0.100 |
Why?
|
Meta-Analysis as Topic | 2 | 2017 | 1376 | 0.100 |
Why?
|
Temperance | 1 | 2011 | 87 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2020 | 5201 | 0.090 |
Why?
|
Blood Glucose | 3 | 2019 | 6381 | 0.090 |
Why?
|
Polymorphism, Genetic | 2 | 2022 | 4291 | 0.090 |
Why?
|
Thiazoles | 3 | 2024 | 1511 | 0.090 |
Why?
|
Algorithms | 8 | 2020 | 13981 | 0.090 |
Why?
|
Disability Evaluation | 1 | 2017 | 1826 | 0.080 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2010 | 97 | 0.080 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1428 | 0.080 |
Why?
|
Fluoroscopy | 3 | 2008 | 948 | 0.080 |
Why?
|
Thromboembolism | 1 | 2016 | 1017 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2019 | 15789 | 0.080 |
Why?
|
Predictive Value of Tests | 6 | 2016 | 15289 | 0.080 |
Why?
|
Task Performance and Analysis | 2 | 2017 | 759 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3839 | 0.080 |
Why?
|
Catheter-Related Infections | 1 | 2012 | 273 | 0.080 |
Why?
|
Cerebellum | 2 | 2012 | 1496 | 0.080 |
Why?
|
Prognosis | 4 | 2013 | 29658 | 0.080 |
Why?
|
Life Change Events | 1 | 2014 | 952 | 0.080 |
Why?
|
Self Report | 1 | 2020 | 3711 | 0.080 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2009 | 141 | 0.080 |
Why?
|
History, 21st Century | 1 | 2015 | 1575 | 0.080 |
Why?
|
Angiocardiography | 1 | 2008 | 153 | 0.080 |
Why?
|
Perioperative Care | 1 | 2016 | 1037 | 0.080 |
Why?
|
Hemodynamics | 2 | 2023 | 4174 | 0.080 |
Why?
|
Emotions | 2 | 2023 | 2734 | 0.080 |
Why?
|
Exercise Therapy | 1 | 2015 | 919 | 0.080 |
Why?
|
Immunomodulation | 1 | 2012 | 547 | 0.080 |
Why?
|
Software | 2 | 2020 | 4419 | 0.080 |
Why?
|
Child Abuse | 1 | 2017 | 1067 | 0.080 |
Why?
|
Triglycerides | 1 | 2016 | 2476 | 0.080 |
Why?
|
Genetic Association Studies | 2 | 2015 | 2717 | 0.070 |
Why?
|
Beverages | 1 | 2013 | 820 | 0.070 |
Why?
|
Hip Fractures | 1 | 2016 | 989 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 5 | 2022 | 17790 | 0.070 |
Why?
|
Extrapyramidal Tracts | 1 | 2006 | 17 | 0.070 |
Why?
|
Antibiotic Prophylaxis | 1 | 2012 | 643 | 0.070 |
Why?
|
Magnetic Resonance Angiography | 2 | 2011 | 1431 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2012 | 857 | 0.070 |
Why?
|
Visual Cortex | 1 | 2014 | 1089 | 0.070 |
Why?
|
Sound Spectrography | 4 | 2000 | 113 | 0.070 |
Why?
|
Neocortex | 1 | 2010 | 416 | 0.070 |
Why?
|
Respiratory Tract Infections | 1 | 2014 | 1007 | 0.070 |
Why?
|
Linear Models | 4 | 2018 | 5877 | 0.070 |
Why?
|
Radiography | 3 | 2013 | 6965 | 0.070 |
Why?
|
Reference Values | 5 | 2008 | 4925 | 0.070 |
Why?
|
Visual Perception | 1 | 2014 | 1374 | 0.070 |
Why?
|
Behavior, Addictive | 1 | 2011 | 462 | 0.070 |
Why?
|
Blood-Brain Barrier | 1 | 2012 | 1019 | 0.060 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2009 | 387 | 0.060 |
Why?
|
Insulin | 2 | 2019 | 6597 | 0.060 |
Why?
|
Risk Factors | 9 | 2017 | 74359 | 0.060 |
Why?
|
Hand | 1 | 2010 | 903 | 0.060 |
Why?
|
Early Diagnosis | 2 | 2009 | 1180 | 0.060 |
Why?
|
Mental Status Schedule | 2 | 2016 | 314 | 0.060 |
Why?
|
Water | 2 | 2023 | 1407 | 0.060 |
Why?
|
Single-Blind Method | 2 | 2019 | 1578 | 0.060 |
Why?
|
Nasal Cavity | 1 | 1987 | 304 | 0.060 |
Why?
|
Pyramidal Tracts | 1 | 2006 | 250 | 0.060 |
Why?
|
Head | 2 | 2022 | 922 | 0.060 |
Why?
|
Fever | 1 | 2012 | 1617 | 0.060 |
Why?
|
Synaptic Transmission | 1 | 2011 | 1171 | 0.060 |
Why?
|
Adolescent | 12 | 2023 | 87810 | 0.060 |
Why?
|
Autoimmunity | 1 | 2012 | 1370 | 0.060 |
Why?
|
Electromagnetic Fields | 2 | 2003 | 296 | 0.060 |
Why?
|
Age of Onset | 3 | 2021 | 3301 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2014 | 65017 | 0.060 |
Why?
|
Iron | 1 | 2012 | 1786 | 0.060 |
Why?
|
Verbal Learning | 1 | 2006 | 462 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15687 | 0.060 |
Why?
|
Basal Ganglia | 1 | 2006 | 552 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1881 | 0.050 |
Why?
|
Time Factors | 5 | 2018 | 40165 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8552 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 3201 | 0.050 |
Why?
|
Muscle Hypertonia | 1 | 2022 | 12 | 0.050 |
Why?
|
Cross Infection | 1 | 2012 | 1434 | 0.050 |
Why?
|
Schizophrenia | 3 | 2014 | 6915 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 3150 | 0.050 |
Why?
|
Evoked Potentials, Visual | 1 | 2005 | 415 | 0.050 |
Why?
|
Absorptiometry, Photon | 1 | 2008 | 1736 | 0.050 |
Why?
|
Factor Analysis, Statistical | 2 | 2016 | 998 | 0.050 |
Why?
|
Lateral Ventricles | 2 | 2017 | 146 | 0.050 |
Why?
|
Acute Disease | 1 | 2012 | 7269 | 0.050 |
Why?
|
Disease Management | 1 | 2012 | 2514 | 0.050 |
Why?
|
Asymptomatic Diseases | 1 | 2024 | 587 | 0.050 |
Why?
|
Reading | 1 | 2004 | 529 | 0.050 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 1215 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2013 | 3562 | 0.050 |
Why?
|
Chlorofluorocarbons | 1 | 2000 | 12 | 0.050 |
Why?
|
Radiography, Interventional | 1 | 2008 | 1114 | 0.050 |
Why?
|
Motor Activity | 1 | 2010 | 2687 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2008 | 1183 | 0.040 |
Why?
|
Anticoagulants | 1 | 2016 | 4897 | 0.040 |
Why?
|
Thrombolytic Therapy | 1 | 2009 | 2108 | 0.040 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2000 | 144 | 0.040 |
Why?
|
Therapeutic Equivalency | 1 | 2000 | 136 | 0.040 |
Why?
|
Comorbidity | 1 | 2015 | 10551 | 0.040 |
Why?
|
Sepsis | 1 | 2014 | 2592 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39261 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2802 | 0.040 |
Why?
|
Intelligence | 1 | 2005 | 921 | 0.040 |
Why?
|
Occipital Lobe | 2 | 2014 | 373 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2895 | 0.040 |
Why?
|
Choice Behavior | 1 | 2005 | 821 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 6498 | 0.040 |
Why?
|
Afghanistan | 1 | 2019 | 79 | 0.040 |
Why?
|
Iraq | 1 | 2019 | 94 | 0.040 |
Why?
|
Lymphoma, Follicular | 1 | 2003 | 453 | 0.040 |
Why?
|
Magnetics | 1 | 2002 | 600 | 0.040 |
Why?
|
Multicenter Studies as Topic | 2 | 2017 | 1722 | 0.040 |
Why?
|
Prospective Studies | 5 | 2016 | 54303 | 0.040 |
Why?
|
Genetic Variation | 1 | 2014 | 6551 | 0.040 |
Why?
|
Regression Analysis | 3 | 2017 | 6360 | 0.040 |
Why?
|
Receptors, Glutamate | 1 | 1999 | 229 | 0.040 |
Why?
|
Supine Position | 1 | 2019 | 205 | 0.040 |
Why?
|
Neurotoxins | 1 | 1999 | 240 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1126 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2010 | 5791 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2014 | 12427 | 0.040 |
Why?
|
Hepatitis B | 1 | 2003 | 701 | 0.040 |
Why?
|
Trinucleotide Repeats | 2 | 2011 | 257 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2007 | 2634 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2008 | 2176 | 0.040 |
Why?
|
Bone and Bones | 1 | 2008 | 2560 | 0.040 |
Why?
|
Ethanol | 1 | 2023 | 1323 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15757 | 0.040 |
Why?
|
Snoring | 1 | 2019 | 206 | 0.040 |
Why?
|
Sleep | 2 | 2023 | 4751 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 2000 | 1156 | 0.040 |
Why?
|
Electric Stimulation Therapy | 1 | 2003 | 613 | 0.030 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2016 | 22 | 0.030 |
Why?
|
Cardiology | 1 | 2008 | 1723 | 0.030 |
Why?
|
Corpus Striatum | 2 | 2017 | 1233 | 0.030 |
Why?
|
Cholinergic Agents | 1 | 1996 | 96 | 0.030 |
Why?
|
Immunotoxins | 1 | 1996 | 175 | 0.030 |
Why?
|
Models, Statistical | 4 | 2016 | 5075 | 0.030 |
Why?
|
Hemoglobins | 1 | 2022 | 1521 | 0.030 |
Why?
|
Pons | 1 | 1997 | 239 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9467 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2022 | 1738 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2016 | 369 | 0.030 |
Why?
|
Taste | 1 | 1996 | 188 | 0.030 |
Why?
|
Quality Control | 2 | 2008 | 828 | 0.030 |
Why?
|
Neurotransmitter Agents | 1 | 1999 | 663 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2000 | 1809 | 0.030 |
Why?
|
Conditioning, Operant | 1 | 1996 | 308 | 0.030 |
Why?
|
Triazines | 1 | 2017 | 310 | 0.030 |
Why?
|
Bone Density | 1 | 2008 | 3534 | 0.030 |
Why?
|
Spain | 1 | 2016 | 488 | 0.030 |
Why?
|
Receptors, GABA-A | 1 | 1999 | 621 | 0.030 |
Why?
|
Animals | 6 | 2014 | 167963 | 0.030 |
Why?
|
Brain Edema | 1 | 1999 | 603 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 12965 | 0.030 |
Why?
|
Posture | 1 | 2019 | 953 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 786 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2023 | 80372 | 0.030 |
Why?
|
Genome-Wide Association Study | 3 | 2022 | 12626 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2015 | 478 | 0.030 |
Why?
|
Psychological Tests | 1 | 2016 | 639 | 0.030 |
Why?
|
Waist Circumference | 1 | 2017 | 926 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2022 | 2512 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 29749 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2003 | 9185 | 0.030 |
Why?
|
Databases, Factual | 3 | 2016 | 8035 | 0.030 |
Why?
|
Body Mass Index | 1 | 2010 | 12914 | 0.030 |
Why?
|
United States | 5 | 2022 | 72461 | 0.030 |
Why?
|
Nonlinear Dynamics | 2 | 2005 | 494 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2013 | 281 | 0.020 |
Why?
|
Publication Bias | 1 | 2012 | 162 | 0.020 |
Why?
|
Astrocytes | 1 | 1999 | 1338 | 0.020 |
Why?
|
Thalamus | 1 | 2017 | 1041 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 1784 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2016 | 1489 | 0.020 |
Why?
|
Autopsy | 1 | 2014 | 1007 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2023 | 4013 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23376 | 0.020 |
Why?
|
Observation | 1 | 2012 | 312 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2014 | 1850 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1266 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3765 | 0.020 |
Why?
|
Automation, Laboratory | 1 | 2010 | 103 | 0.020 |
Why?
|
Research Design | 2 | 2018 | 6180 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 14660 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1650 | 0.020 |
Why?
|
Photomicrography | 1 | 2009 | 71 | 0.020 |
Why?
|
Rats | 3 | 2014 | 23711 | 0.020 |
Why?
|
Sclerosis | 1 | 2009 | 210 | 0.020 |
Why?
|
Pattern Recognition, Visual | 2 | 2005 | 810 | 0.020 |
Why?
|
Exercise Test | 1 | 2016 | 2128 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2012 | 940 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2012 | 2696 | 0.020 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2010 | 263 | 0.020 |
Why?
|
Data Collection | 2 | 2008 | 3315 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2010 | 783 | 0.020 |
Why?
|
Heart Rate | 1 | 2000 | 4179 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2012 | 1975 | 0.020 |
Why?
|
Multiple Sclerosis | 1 | 2003 | 3204 | 0.020 |
Why?
|
Neuroradiography | 1 | 2008 | 71 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2014 | 2061 | 0.020 |
Why?
|
Depression | 2 | 2019 | 8044 | 0.020 |
Why?
|
Child | 5 | 2018 | 79806 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2016 | 2007 | 0.020 |
Why?
|
X-Rays | 1 | 2008 | 307 | 0.020 |
Why?
|
Fourier Analysis | 2 | 2003 | 439 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9411 | 0.020 |
Why?
|
Respiratory Function Tests | 2 | 2003 | 1683 | 0.020 |
Why?
|
Chronic Disease | 3 | 2014 | 9287 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2773 | 0.020 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 1987 | 104 | 0.020 |
Why?
|
Mathematical Computing | 1 | 2006 | 143 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2014 | 1430 | 0.020 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2019 | 1860 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5125 | 0.020 |
Why?
|
Electrophysiology | 1 | 2008 | 1265 | 0.020 |
Why?
|
Creatinine | 1 | 2010 | 1903 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 848 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10547 | 0.020 |
Why?
|
Pulmonary Ventilation | 1 | 1987 | 371 | 0.020 |
Why?
|
Canada | 1 | 2010 | 2128 | 0.010 |
Why?
|
Online Systems | 1 | 2005 | 181 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2006 | 622 | 0.010 |
Why?
|
Education | 1 | 2007 | 534 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1343 | 0.010 |
Why?
|
Reference Standards | 1 | 2008 | 1004 | 0.010 |
Why?
|
Radiation Protection | 1 | 2008 | 425 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3696 | 0.010 |
Why?
|
Plaque, Amyloid | 1 | 2008 | 758 | 0.010 |
Why?
|
Hemorrhage | 1 | 2016 | 3600 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18137 | 0.010 |
Why?
|
Intelligence Tests | 1 | 2005 | 500 | 0.010 |
Why?
|
Child, Preschool | 2 | 2018 | 42063 | 0.010 |
Why?
|
Verbal Behavior | 1 | 2005 | 335 | 0.010 |
Why?
|
Dyslexia | 1 | 2004 | 208 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12159 | 0.010 |
Why?
|
Angiography | 1 | 2008 | 1605 | 0.010 |
Why?
|
Lamivudine | 1 | 2003 | 363 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9631 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2011 | 2062 | 0.010 |
Why?
|
Sound | 1 | 2003 | 257 | 0.010 |
Why?
|
Semantics | 1 | 2004 | 599 | 0.010 |
Why?
|
Models, Psychological | 1 | 2005 | 827 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2008 | 1880 | 0.010 |
Why?
|
Markov Chains | 1 | 2004 | 968 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2003 | 13630 | 0.010 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2003 | 693 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2852 | 0.010 |
Why?
|
Hepatitis B virus | 1 | 2003 | 522 | 0.010 |
Why?
|
Echo-Planar Imaging | 1 | 2004 | 657 | 0.010 |
Why?
|
Equipment Design | 1 | 2007 | 3520 | 0.010 |
Why?
|
Epilepsy | 1 | 2014 | 3267 | 0.010 |
Why?
|
Electromagnetic Phenomena | 1 | 2000 | 161 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7475 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2005 | 1967 | 0.010 |
Why?
|
Syndrome | 1 | 2004 | 3280 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9716 | 0.010 |
Why?
|
Image Enhancement | 1 | 2008 | 2881 | 0.010 |
Why?
|
Water Deprivation | 1 | 1996 | 19 | 0.010 |
Why?
|
Saccharin | 1 | 1996 | 20 | 0.010 |
Why?
|
Ribosome Inactivating Proteins, Type 1 | 1 | 1996 | 27 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4107 | 0.010 |
Why?
|
Biogenic Monoamines | 1 | 1996 | 50 | 0.010 |
Why?
|
DNA | 1 | 2010 | 7233 | 0.010 |
Why?
|
Artifacts | 1 | 2005 | 1898 | 0.010 |
Why?
|
N-Glycosyl Hydrolases | 1 | 1996 | 68 | 0.010 |
Why?
|
Choline O-Acetyltransferase | 1 | 1996 | 155 | 0.010 |
Why?
|
Drinking Behavior | 1 | 1996 | 103 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2008 | 4563 | 0.010 |
Why?
|
Microinjections | 1 | 1996 | 321 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2004 | 2326 | 0.010 |
Why?
|
Biopsy | 1 | 2007 | 6771 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13314 | 0.010 |
Why?
|
Vocal Cord Paralysis | 2 | 1990 | 272 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 2000 | 565 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4407 | 0.010 |
Why?
|
Massachusetts | 1 | 2005 | 8803 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2003 | 2781 | 0.010 |
Why?
|
Genetic Testing | 1 | 2005 | 3531 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15697 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2003 | 3061 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16546 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2004 | 2557 | 0.010 |
Why?
|
Bronchial Diseases | 1 | 1990 | 151 | 0.000 |
Why?
|
Risk Assessment | 1 | 2010 | 24123 | 0.000 |
Why?
|
Bronchitis | 1 | 1987 | 196 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8158 | 0.000 |
Why?
|
Psychophysiologic Disorders | 1 | 1987 | 221 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81208 | 0.000 |
Why?
|
Larynx | 1 | 1990 | 492 | 0.000 |
Why?
|
Laryngectomy | 1 | 1987 | 243 | 0.000 |
Why?
|
Pulmonary Emphysema | 1 | 1990 | 688 | 0.000 |
Why?
|
Mutation | 1 | 2003 | 29932 | 0.000 |
Why?
|